Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 818-826

  Bickerdike, Michael J ^a,b   Abercrombie, Elizabeth D ^a  

^a RUTGERS UNIVERSITY   (United States)

^b Cerebrus Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; DOPAMINE;

ACETYLCHOLINE RELEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ACETYLCHOLINE; AMPHETAMINE; ANIMALS; CORPUS STRIATUM; MALE; MICRODIALYSIS; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030756178     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. ACQUAS, E., WILSON, C. AND FIBIGER, H. C.: Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo. J. Pharmacol. Exp. Ther. 281: 360-368, 1997.
2. AKIMOTO, K., HAMAMURA, T., KAZAHAVA, Y., AKIYAMA, K. AND OTSUKI, S.: Enhanced extracellular dopamine level may be fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine - An in vivo dialysis study in freely moving rats. Brain Res. 507: 344-346, 1990.
3. ARNFRED, T. AND RANDRUP, A.: Cholinergic mechanisms in brain inhibiting amphetamine-induced stereotyped behavior. Acta Pharmacol. Toxicol. 26: 384-394, 1968.
4. BARNETT, J. A., SEGAL, D. S. AND KUCZENSKI, R.: Repeated amphetamine pre-treatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization. J. Pharmacol. Exp. Ther. 242: 40-47, 1987.
5. 3H]acetylcholine in rat striatal slices: An experimental model for drugs that enhance dopaminergic transmission. J. Neurochem. 44: 331-337, 1985.
6. 2 dopaminergic regulation of acetylcholine release from striata of freely moving rats. J. Neurochem. 54: 2145-2148, 1990.
7. 1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J. Pharmacol. Exp. Ther. 277: 1177-1187, 1996.
8. CADOR, M., BJIJOU, Y. AND STINUS, L.: Evidence for a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65: 385-395, 1995.
9. CASTENEDA, E., BECKER, J. B. AND ROBINSON, T. E.: The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci. 42: 2447-2456, 1988.
10. COSTALL, B. AND NAYLOR, R. J.: Modification of amphetamine effects by intracerebrally administered anticholinergic agents. Life Sci. 11: 239-253, 1972.
11. CREESE, I. AND IVERSEN, S. D.: The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83: 419-436, 1975.
12. DAMSMA, G., WESTERINK, B. H. C., DE VRIES, J. B., VAN DEN BERG, C. J. AND HORN, A. S.: Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis. J. Neurochem. 48: 1523-1528, 1987.
13. DAMSMA, G., DE BOER, P., WESTERINK, B. H. C. AND FIBIGER, H. C.: Dopaminergic regulation of striatal cholinergic interneurons: An in vivo microdialysis study. Naunyn-Schmiedeberg Arch. Pharmacol. 342: 523-527, 1990a.
14. DAMSMA, G., THAM, C. -S., ROBERTSON, G. S. AND FIBIGER, H. C.: Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. Eur. J. Pharmacol. 186: 335-338, 1990b.
15. DAMSMA, G., ROBERTSON, G. S., THAM, C. -S. AND FIBIGER, H. C.: Dopaminergic regulation of striatal acetylcholine release: Importance of D1 and N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 259: 1064-1072, 1991.
16. DE BOER, P. AND ABERCROMBIE, E. D.: Further characterization of the role of substantia nigra in the modulation of striatal acetylcholine in awake rats. Soc. Neurosci. Abstr. 20: 126, 1994.
17. DE BOER, P. AND ABERCROMBIE, E. D.: Physiological release of striatal acetylcholine in vivo: Modulation by D1 and D2 dopamine receptor subtypes. J. Pharmacol. Exp, Ther. 277: 775-783, 1996.
18. DICHIARA, G. AND IMPERATO, A.: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85: 5274-5278, 1988.
19. DOWNS, A. W. AND EDDY, N. B.: The effect of repeated doses of cocaine on the rat. J. Pharmacol. Exp. Ther. 46: 199-202, 1932.
20. ELLINWOOD, E. H., SUDILOVSKY, A. AND BELSON, L. M.: Evolving behavior in the clinical and experimental amphetamine model psychosis. Am. J. Psychiat. 103: 1088-1093, 1973.
21. FORLONI, G., BIDZINSKI, A., FUSI, R., LADINSKY, H. AND CONSOLO, S.: Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation. Life Sci. 41: 1717-1723, 1987.
22. GONZALEZ, L. P. AND ELLINWOOD, E. H.: Cholinergic modulation of stimulant-induced behavior. Pharmacol. Biochem. Behav. 20: 397-403, 1984.
23. HAMAMURA, T., AKIYAMA, K., AKIMOTO, K., KASHIHARA, K., OKUMURA, K., UJIKE, H. AND OTSUKI, S.: Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 54: 40-46, 1991.
24. HEIDBREDER, C. A. AND SHIPPENBERG, T. S.: Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine. Synapse 24: 182-192, 1996.
25. HEIDBREDER, C. A., THOMPSON, A. C. AND SHIPPENBERG, T. S.: Role of dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 278: 490-502, 1996.
26. IMPERATO, A., OBINU, M. C., DAZZI, L. AND GESSA, G. L.: Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo? Eur. J. Pharmacol. 251: 271-279, 1994.
27. KALIVAS, P. W. AND DUFFY, P.: Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release. J. Neurochem. 50: 1498-1504, 1988.
28. KALIVAS, P. W. AND DUFFY, P.: Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13: 276-284, 1993.
29. KALIVAS, P. W. AND STEWART, J.: Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. Rev. 16: 223-244, 1991.
30. KALIVAS, P. W., SORG, B. A. AND HOOKS, M. S.: The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4: 315-334, 1993.
31. KARLER, R., CALDER, L. D., CHAUDRY, I. A. AND TURKANIS, S. A.: Blockade of "reverse tolerance' to cocaine and amphetamine by MK 801. Life Sci. 45: 599-606, 1989.
32. KARLER, R., CALDER, L. D. AND TURKANIS, S. A.: DNQX blockade of amphetamine behavioral sensitization. Brain Res. 552: 295-300, 1991.
33. KAZAHAYA, Y., AKIMOTO, K. AND OTSUKI, S.: Subchronic methamphetamine treatment enhances methamphetamine-or cocaine-induced dopamine efflux in vivo. Biol. Psychiat. 25: 902-912, 1989.
34. KITAI, S. T. AND SURMEIER, D. J.: Cholinergic and dopaminergic modulation of potassium conductances in neostriatal neurons. In Advances in Neurology, Vol. 60, ed. by N. Narabayashi, T. Nagatsu, N. Yanagisawa and Y. Mizuno, pp. 40-52, Raven Press, New York, NY, 1993.
35. KOLTA, M. G., SHREVE, P., DESOUZA, V. AND URETSKY, N. J.: Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24: 823-829, 1985.
36. LEHMANN, J. AND LANGER, S. Z.: The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? Neuroscience 10: 1105-1120, 1983.
37. 2 dopamine receptor gene expression by cholinergic neurons in the rat striatum. Neurosci. Lett. 117: 248-252, 1990.
38. OHMORI, T., ABEKAWA, T. AND KOYAMA, T.: Scopolamine prevents the development of behavioral sensitization. Life Sci. 56: 1223-1229, 1995a.
39. OHMORI, T., ABEKAWA, T. AND KOYAMA, T.: Scopolamine prevents the augmentation of stereotypy induced by chronic methamphetamine treatment. Psychopharmacology 121: 158-163, 1995b.
40. PATRICK, S. L., THOMPSON, T. L., WALKER, J. M. AND PATRICK, R. L.: Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus. Brain Res. 538: 343-346, 1991.
41. PAULSON, P. E., CAMP, D. M. AND ROBINSON, T. E.: Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 103: 480-492, 1991.
42. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA, 1986.
43. PERUGINI, M. AND VEZINA, P.: Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J. Pharmacol. Exp. Ther. 270: 690-696, 1994.
44. PIERCE, R. C., BELL, K., DUFFY, P. AND KALIVAS, P. W.: Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16: 1550-1560, 1996.
45. POST, R. M. AND ROSE, H.: Increasing effects of repetitive cocaine administration in the rat. Nature 260: 731-732, 1976.
46. REID, M. S. AND BERGER, S. P.: Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport 7: 1325-1329, 1996.
47. ROBERTSON, M. W., LESLIE, C. A. AND BENNET, J. P., JR.: Apparent synapitc dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res. 538: 337-339, 1991.
48. ROBINSON, T. E. AND BECKER, J. B.: Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur. J. Pharmacol. 85: 253-254, 1982.
49. ROBINSON, T. E. AND BECKER, J. B.: Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11: 157-198, 1986.
50. ROBINSON, T. E. AND BERRIDGE, K. C.: The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Rev. 18: 247-291, 1993.
51. ROBINSON, T. E., JURSON, P. A., BENNET, J. A. AND BENTGEN, K, M.: Persistant sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: A microdialysis study in freely moving rats. Brain Res. 462: 211-222, 1988.
52. SATO, M., CHEN, C. -C., AKIYAMA, K. AND OTSUKI, S.: A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann. N.Y. Acad. Sci. 654: 160-170, 1992.
53. SCATTON, B.: Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: Evidence against receptor multiplicity. J. Pharmacol. Exp. Ther. 220: 197-202, 1982.
54. SEGAL, D. S. AND KUCZENSKI, R.: Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577: 351-355, 1992a.
55. SEGAL, D. S. AND KUCZENSKI, R.: In vivo microdiaiysis reveals a diminished amphetamine-induced dopamine response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 571: 330-337, 1992b.
56. SEGAL, D. S. AND MANDELL, A. J.: Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2: 249-255, 1974.
57. STEWART, J. AND DRUHAN, J. P.: Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology 110: 125-132, 1993.
58. TIMMERMAN, W. AND ABERCROMBIE, E. D.: Amphetamine-induced release of den-dritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects. Synapse 23: 280-291, 1996.
59. TJON, G. H. K., DE VRIES, T. J., NESTBY, P., WARDEH, G., MULDER, A. H AND SCHOFFELMEER, A. N. M.: Intermittent and chronic morphine treatment induces long-lasting changes in ∂-opioid receptor-regulated acetylcholine release in the rat striatum and nucleus accumbens. Eur. J. Pharmacol. 283: 169-176, 1995.
60. VEZINA, P. AND STEWART, J.: Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects. Brain Res. 516: 99-106, 1990.
61. VEZINA, P., GIOVINO, A. A., WISE, R. A. AND STEWART, J.: Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine. Pharmacol. Biochem. Behav. 32: 581-584, 1989.
62. WANG, J. Q. AND MCGINTY, J. F.: Glutamatergic and cholinergic regulation of immediate-early gene and neuropeptide gene expression in the striatum. In Pharmacological Regulation of Gene Expression in the CNS, ed. by K. Merchant, pp. 81-113, CRC Press, New York, NY, 1996.
63. WOLF, M. E. AND KHANSA, M. R.: Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562: 164-168, 1991.
64. WOLF, M. E., WHITE, F. J., NASSAR, R., BROODERSON, R. J. AND KHANSA, M. R.: Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264: 249-255, 1993.
65. XUE, C. -J., NG, J. P., LI, Y. AND WOLF, M. E.: Acute and repeated systemic amphetamine administration: Effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J. Neurochem. 67: 352-363, 1996.